Limits...
The factors affecting recurrence of symptoms after infrainguinal arterial endovascular angioplasty.

Bae MJ, Lee JG, Chung SW, Lee CW, Kim CW - Korean J Thorac Cardiovasc Surg (2014)

Bottom Line: The mean age of the patients was 69.60±7.62 years.The presence of a dorsal arch was also a significant factor (relative risk=0.675, p=0.047).Therefore, the usage of lipid-lowering agents after endovascular treatment and taking the presence of a dorsal arch into consideration are important elements of managing the recurrence of symptoms.

View Article: PubMed Central - PubMed

Affiliation: Department of Thoracic and Cardiovascular Surgery, Pusan National University Hospital.

ABSTRACT

Background: This study reports the result of endovascular treatment for arterial occlusive disease limited to femoropopliteal lesions, focusing on the recurrence of symptoms instead of patency.

Methods: This was a retrospective, single-center study. From April 2007 to November 2011, 48 limbs in 38 patients underwent endovascular stenting or balloon angioplasty to treat femoropopliteal arterial occlusive disease. The factors affecting the recurrence of symptoms were analyzed.

Results: The mean age of the patients was 69.60±7.62 years. Among the baseline characteristics of the patients, initial hyperlipidemia was the most important factor affecting the recurrence of symptoms (relative risk=5.810, p=0.031). The presence of a dorsal arch was also a significant factor (relative risk=0.675, p=0.047).

Conclusion: The major factors that affect the recurrence of symptoms after endovascular treatment for femoropopliteal arterial occlusive lesions are hyperlipidemia and the presence of a dorsal arch. Therefore, the usage of lipid-lowering agents after endovascular treatment and taking the presence of a dorsal arch into consideration are important elements of managing the recurrence of symptoms.

No MeSH data available.


Related in: MedlinePlus

Symptom-free rates related to (A) hyperlipidemia (p=0.031), and (B) the presence of a dorsal arch (p=0.047). All factors were analyzed by survival analysis.
© Copyright Policy
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4279828&req=5

f1-kjtcvs-47-517: Symptom-free rates related to (A) hyperlipidemia (p=0.031), and (B) the presence of a dorsal arch (p=0.047). All factors were analyzed by survival analysis.

Mentions: There were eight patients with hyperlipidemia with 10 involved limbs, which was the basis for our statistical analysis. The differences between the groups with and without hyperlipidemia are summarized in Table 4. The recurrence of symptoms in patients with hyperlipidemia was 5.8 times higher than that in patients without hyperlipidemia according to the Cox regression models (p=0.031) (Table 3, Fig. 1A). There were also statistically significant differences in the recurrence of symptoms and the symptom-free duration even though there were more TASC C and D lesions in patients without hyperlipidemia (Table 4).


The factors affecting recurrence of symptoms after infrainguinal arterial endovascular angioplasty.

Bae MJ, Lee JG, Chung SW, Lee CW, Kim CW - Korean J Thorac Cardiovasc Surg (2014)

Symptom-free rates related to (A) hyperlipidemia (p=0.031), and (B) the presence of a dorsal arch (p=0.047). All factors were analyzed by survival analysis.
© Copyright Policy
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4279828&req=5

f1-kjtcvs-47-517: Symptom-free rates related to (A) hyperlipidemia (p=0.031), and (B) the presence of a dorsal arch (p=0.047). All factors were analyzed by survival analysis.
Mentions: There were eight patients with hyperlipidemia with 10 involved limbs, which was the basis for our statistical analysis. The differences between the groups with and without hyperlipidemia are summarized in Table 4. The recurrence of symptoms in patients with hyperlipidemia was 5.8 times higher than that in patients without hyperlipidemia according to the Cox regression models (p=0.031) (Table 3, Fig. 1A). There were also statistically significant differences in the recurrence of symptoms and the symptom-free duration even though there were more TASC C and D lesions in patients without hyperlipidemia (Table 4).

Bottom Line: The mean age of the patients was 69.60±7.62 years.The presence of a dorsal arch was also a significant factor (relative risk=0.675, p=0.047).Therefore, the usage of lipid-lowering agents after endovascular treatment and taking the presence of a dorsal arch into consideration are important elements of managing the recurrence of symptoms.

View Article: PubMed Central - PubMed

Affiliation: Department of Thoracic and Cardiovascular Surgery, Pusan National University Hospital.

ABSTRACT

Background: This study reports the result of endovascular treatment for arterial occlusive disease limited to femoropopliteal lesions, focusing on the recurrence of symptoms instead of patency.

Methods: This was a retrospective, single-center study. From April 2007 to November 2011, 48 limbs in 38 patients underwent endovascular stenting or balloon angioplasty to treat femoropopliteal arterial occlusive disease. The factors affecting the recurrence of symptoms were analyzed.

Results: The mean age of the patients was 69.60±7.62 years. Among the baseline characteristics of the patients, initial hyperlipidemia was the most important factor affecting the recurrence of symptoms (relative risk=5.810, p=0.031). The presence of a dorsal arch was also a significant factor (relative risk=0.675, p=0.047).

Conclusion: The major factors that affect the recurrence of symptoms after endovascular treatment for femoropopliteal arterial occlusive lesions are hyperlipidemia and the presence of a dorsal arch. Therefore, the usage of lipid-lowering agents after endovascular treatment and taking the presence of a dorsal arch into consideration are important elements of managing the recurrence of symptoms.

No MeSH data available.


Related in: MedlinePlus